Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Haemapheresis activities in Germany.

Rainer Moog1

  • 1Institute for Transfusion Medicine, University Clinics Essen, Hufelandstrasse 55, 45122 Essen, Germany. rainer.moog@uni-essen.de

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
|June 10, 2005
PubMed
Summary

Apheresis in Germany primarily collects plasma and platelets for therapeutic use. While stem cell collections rise, data on therapeutic apheresis procedures and side effects remain limited due to a lack of central registration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GMP in donor centres.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2025
Same author

Considerations on the number of plasma donations per donor per year: Pro.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2025
Same author

Challenges for Plasma-Derived Medicinal Products.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie·2023
Same author

Safety of Plasmapheresis in Donors with Low IgG Levels: Results of a Prospective, Controlled Multicentre Study.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie·2023
Same author

COVID 19 convalescent plasma: Is there still a place for CCP?

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2023
Same author

Reply to the Letter-to-the-Editor Comment to Moog et al.: Safety of Plasmapheresis in Donors with Low IgG Levels: Results of a Prospective, Controlled Multicentre Study.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie·2023

Area of Science:

  • Transfusion Medicine
  • Hematology

Background:

  • Apheresis procedures, both preparative and therapeutic, are established in Germany.
  • Plasma and platelets are the most frequently collected products via apheresis.

Purpose of the Study:

  • To summarize the current status of apheresis in Germany.
  • To highlight the types of products collected and their uses.
  • To identify limitations in data collection for therapeutic apheresis.

Main Methods:

  • Analysis of collected apheresis data from 2002.
  • Review of established and emerging apheresis techniques.

Main Results:

  • In 2002, 1,090,329L of plasma and significant transfusion units (TUs) of plasma (410,507) and platelets (227,096) were collected for therapeutic purposes.

Related Experiment Videos

  • Allogeneic and autologous peripheral blood stem cell collections are increasing, replacing bone marrow harvesting.
  • The market for apheresis-collected red blood cells (4982 TUs) and multicomponent donations is small.
  • No central register exists for therapeutic apheresis data, hindering accurate assessment of procedures and side effects.

    • Conclusions:

    • Apheresis is a vital component of Transfusion Medicine in Germany, with plasma and platelets being key products.
    • The increasing use of stem cell apheresis signifies a shift in collection methods.
    • The absence of a central registry for therapeutic apheresis is a significant data gap.
    • Emerging therapeutic apheresis techniques show promise for treating various conditions.